Mimedx (MDXG) Total Debt (2011 - 2026)
Mimedx (MDXG) reported Total Debt of $17.6 million for Q1 2026, down 5.7% on a YoY basis from $18.7 million in Q1 2025, and down 2.08% sequentially from $18.0 million in Q4 2025.
Mimedx (MDXG) Total Debt (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 12 years of Total Debt data on file, last reported at $17.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 5.7% year-over-year to $17.6 million; the trailing twelve-month figure through Mar 2026 stood at $17.6 million (down 5.7% YoY), and the FY2025 full-year result was $18.0 million, down 4.58% from the prior year.
- Total Debt retreated to $17.6 million in Q1 2026, from $18.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $49.0 million in Q3 2023 to a low of $17.6 million in Q1 2026.
- A 5-year average of $32.8 million and a median of $20.4 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt rose 1.01% in 2023 and plunged 61.16% in 2024, its largest moves.
- Tracing MDXG's Total Debt over 5 years: stood at $48.6 million in 2022, then decreased by 1.02% to $48.1 million in 2023, then plunged by 60.85% to $18.8 million in 2024, then retreated by 4.58% to $18.0 million in 2025, then declined by 2.08% to $17.6 million in 2026.
- Business Quant data shows MDXG's Total Debt at $17.6 million in Q1 2026, $18.0 million in Q4 2025, and $18.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 17.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.59 Mn |
| Dec 31, 2025 | 17.97 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.46 Mn |
| Mar 31, 2025 | 18.66 Mn |
| Dec 31, 2024 | 18.83 Mn |
| Sep 30, 2024 | 19.02 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 19.45 Mn |
| Dec 31, 2023 | 48.10 Mn |
| Sep 30, 2023 | 48.97 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Mar 31, 2023 | 48.71 Mn |
| Dec 31, 2022 | 48.59 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Mar 31, 2022 | 48.24 Mn |
| Dec 31, 2021 | 48.13 Mn |
| Sep 30, 2021 | 50.00 Mn |
| Jun 30, 2021 | 47.91 Mn |